Drug Approval | December 17, 2023
Zydus receives final USFDA approval for Cyclophosphamide Capsules USP, 25 mg and 50 mg
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cell
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cell
The product will be manufactured at Lupin’s Nagpur facility in India
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic, and prostate cancer
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
Specialized cancer care will be offered to cancer patients making it accessible and affordable. We have adopted a patient-centric approach.
Subscribe To Our Newsletter & Stay Updated
